Norgine

Founded in 1906, Norgine stands as a distinguished European specialist pharmaceutical company with a rich history spanning over a century. Headquartered in The Netherlands, the company is dedicated to bringing transformative medicines to patients, focusing on critical therapeutic areas. Its operations are deeply rooted in scientific advancement and a commitment to improving healthcare outcomes across Europe and beyond. Norgine's industry focus lies within Pharmaceuticals and Healthcare, leveraging its extensive experience to develop and distribute specialized treatments.

With a workforce of 1,000-5,000 employees and operating across 7 locations, Norgine demonstrates significant scale and a broad geographic reach. The company's product portfolio includes specialist pharmaceuticals, supportive care, and treatments for areas such as cancer, reflecting a strategic approach to unmet medical needs. Norgine's operational structure and global presence are supported by a dedicated team, and you can Meet Norgine's team to understand the expertise driving its mission. The company's long-standing presence and continuous innovation underscore its role as a key player in the pharmaceutical landscape.

Norgine achieved a revenue of $641.8M and has a history of strategic financial backing, including a significant financing round in 2016. This financial stability supports its ongoing research, development, and market expansion efforts. The company's business model encompasses both B2B and B2C aspects, serving healthcare providers and patients directly. For a deeper understanding of its financial performance and market position, Explore financial highlights. Norgine's sustained growth and impact are a testament to its enduring commitment to patient well-being and pharmaceutical innovation.